Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association-Reference-Cited by-同舟云学术

Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

Published:2013-01-28 Issue:3 Volume:54 Page:476-490
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Johnson Keith A.,Minoshima Satoshi,Bohnen Nicolaas I.,Donohoe Kevin J.,Foster Norman L.,Herscovitch Peter,Karlawish Jason H.,Rowe Christopher C.,Carrillo Maria C.,Hartley Dean M.,Hedrick Saima,Pappas Virginia,Thies William H.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference80 articles.

1. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

2. Mixed Dementia

3. ACCF Proposed Method for Evaluating the Appropriateness of Cardiovascular Imaging

4. The Efficacy of Diagnostic Imaging

5. Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET across the age spectrum;Nuclear Medicine Communications;2024-09-13

2. Could the Early Detection of Atrial Fibrillation Reduce the Risk of Developing Dementia?;Biomedicines;2024-08-22

3. Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation;Journal of Clinical Medicine;2024-08-12

4. New plasma LC-MS/MS assays for the quantitation of beta-amyloid peptides and identification of apolipoprotein E proteoforms for Alzheimer’s disease risk assessment;Journal of Investigative Medicine;2024-04-30

5. Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls;Journal of Nuclear Medicine;2024-04-25